JANSSEN RESEARCH & DEVELOPMENT LLC (AKA JRD LLC) | Johnson & Johnson | Maryland | state | 2020 | $16,769 | | tax credit/rebate |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2006 | $16,820 | | training reimbursement |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2010 | $16,834 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2012 | $16,858 | | tax credit/rebate |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2010 | $16,925 | | tax credit/rebate |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2004 | $17,000 | | enterprise zone |
Eisai, Inc. | Eisai | North Carolina | state | 2020 | $17,084 | | tax credit/rebate |
United Therapeutics Corporation and Subs. | United Therapeutics | Maryland | state | 2011 | $17,214 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2018 | $17,353 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2015 | $17,469 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2009 | $17,600 | | tax credit/rebate |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2014 | $17,618 | | training reimbursement |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $17,655 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2013 | $17,655 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2017 | $17,711 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2015 | $17,786 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2012 | $17,828 | | property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2016 | $17,837 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2011 | $17,868 | | tax credit/rebate |
IDEXX LABS, INC. | IDEXX Laboratories | Maine | state | 2018 | $17,942 | | property tax abatement |
IDEXX LABS, INC. | IDEXX Laboratories | Maine | state | 2019 | $17,942 | | property tax abatement |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $18,000 | | tax credit/rebate |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2013 | $18,018 | | property tax abatement |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $18,072 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2010 | $18,433 | | tax credit/rebate |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2016 | $18,708 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYS INC | Johnson & Johnson | Tennessee | local | 2009 | $18,774 | | property tax abatement |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2022 | $18,821 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2011 | $18,828 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,023 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | Pennsylvania | state | 2017 | $19,037 | | tax credit/rebate |
Emergent Biosolutions, Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2010 | $19,113 | | tax credit/rebate |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2011 | $19,119 | | property tax abatement |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2013 | $19,136 | | tax credit/rebate |
Janssen Research & Development | Johnson & Johnson | Maryland | state | 2022 | $19,167 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $19,311 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2015 | $19,368 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2005 | $19,409 | | tax credit/rebate |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2005 | $19,498 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2014 | $19,526 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $19,669 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $19,669 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,669 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2013 | $19,669 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2014 | $19,669 | | tax credit/rebate |
CASCADIAN THERAPEUTICS INC | Seattle Genetics Inc. | Washington | state | 2015 | $19,669 | | tax credit/rebate |
CASCADIAN THERAPEUTICS INC | Seattle Genetics Inc. | Washington | state | 2016 | $19,669 | | tax credit/rebate |
Cambrex Corporation | Cambrex | Maryland | state | 2004 | $19,690 | | tax credit/rebate |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $19,850 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2005 | $19,898 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2022 | $19,911 | | tax credit/rebate |
Intervet | Merck | Delaware | state | 2003 | $19,925 | | training reimbursement |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2008 | $20,000 | | grant |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Disetronic Medical Systems, Incorporated | Roche | Indiana | state | 2005 | $20,000 | | training reimbursement |
Albany Molecular Research | Curia Inc. | New York | local | 2008 | $20,029 | | tax credit/rebate; property tax abatement |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2021 | $20,214 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2014 | $20,248 | | tax credit/rebate |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2019 | $20,253 | | tax credit/rebate |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2012 | $20,276 | | training reimbursement |
Amgen, Inc. | Amgen | Maryland | state | 2020 | $20,303 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2020 | $20,518 | | tax credit/rebate |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $20,717 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2019 | $20,803 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2012 | $20,827 | | tax credit/rebate |
PFIZER | Pfizer | Tennessee | local | 2008 | $20,843 | | property tax abatement |
Amgen, Inc. | Amgen | North Carolina | state | 2011 | $20,940 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2018 | $20,975 | | tax credit/rebate |
Pfizer, Inc. (Chapel Hill) | Pfizer | North Carolina | state | 2022 | $20,984 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2010 | $20,997 | | tax credit/rebate |
Baxalta Us Inc | Takeda Pharmaceutical | California | state | 2022 | $20,998 | | training reimbursement |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $21,024 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2011 | $21,226 | | property tax abatement |
Embrex, Inc. | Pfizer | North Carolina | state | 2011 | $21,304 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2022 | $21,412 | | tax credit/rebate |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2006 | $21,485 | | training reimbursement |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2018 | $21,507 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2010 | $21,507 | | tax credit/rebate |
Regeneron at Global View | Regeneron Pharmaceuticals | New York | local | 2019 | $21,588 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2011 | $21,743 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2010 | $21,746 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2020 | $21,750 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2019 | $21,846 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $22,005 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2021 | $22,214 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2022 | $22,434 | | tax credit/rebate |
Apotex Corporation | Apotex Corp. | Illinois | state | 2004 | $22,500 | | grant |
IMMUNE DESIGN CORP | Merck | Washington | state | 2014 | $22,572 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2016 | $22,708 | | tax credit/rebate |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $23,110 | | training reimbursement |